arginine has been researched along with Cardiovascular Stroke in 167 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.80) | 18.7374 |
| 1990's | 44 (26.35) | 18.2507 |
| 2000's | 65 (38.92) | 29.6817 |
| 2010's | 48 (28.74) | 24.3611 |
| 2020's | 7 (4.19) | 2.80 |
| Authors | Studies |
|---|---|
| Choe, CU; Hübner, N; Jensen, M; Müller, C; Patone, G; Saar, K; Schwedhelm, E; Zeller, T | 1 |
| Cacciotti, L; Caminiti, G; Campolongo, G; Gallo, P; Izzo, R; Manzi, MV; Marazzi, G; Mone, P; Santulli, G; Tartaglia, D; Trimarco, V; Varzideh, F | 1 |
| Ranjbar, K | 1 |
| Lake, HA; Lygate, CA; McAndrew, DJ; Neubauer, S; Schneider, JE; Schwedhelm, E; Zervou, S | 1 |
| Castellino, P; Fatuzzo, P; Gaudio, A; Granata, A; Lentini, P; Malatino, L; Rapisarda, F; Sessa, C; Xourafa, A; Zanoli, L | 1 |
| Choe, CU; Jensen, M; Müller, C; Schwedhelm, E; Zeller, T | 1 |
| Banerjee, S; Cader, FA; Yancy, CW | 1 |
| Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E | 1 |
| de Oliveira-Fonoff, AM; Fernandes, F; Fonseca, KCB; Jordão, MR; Mady, C; Pessoa, FG; Ramires, FJA; Salemi, VMC | 1 |
| Al-Malki, AL; Choudhry, H; Helmi, N; Kumosani, AT; Kumosani, TA; Moselhy, SS; Qari, M | 1 |
| He, H; Jiang, H; Li, X; Liu, X; Liu, Y; Wang, H; Wang, S; Yuan, L; Zhang, W | 1 |
| Berkowitz, D; Grönros, J; Jung, C; Kiss, A; Palmér, M; Pernow, J | 1 |
| Buszman, P; Czerwiński, W; Dębiński, M; Kondys, M; Zurek, P | 1 |
| Casella-Filho, A; Chagas, AC; da-Luz, PL; Dourado, PM; Landim, MB | 1 |
| He, H; Li, X; Liu, X; Wang, H; Wang, S; Yuan, L; Zhang, W | 1 |
| Bichat, F; Chagnon, A; Cottin, Y; Guilland, JC; Korandji, C; Lorin, J; Rochette, L; Touzery, C; Vergely, C; Zeller, M | 1 |
| Kim, SW; Lee, M; Lee, Y; McGinn, AN; Nam, K; Olsen, CD; Shin, SK | 1 |
| Chrząszcz, R; Florek, E; Grochowalski, A; Jawień, W; Szpak, D; Undas, A | 1 |
| Mazur, P; Plicner, D; Sadowski, J; Undas, A | 1 |
| Guo, C; Lai, H; Li, J; Wang, C; Wang, L; Wang, Y; Zhu, K | 1 |
| Liu, W; Tang, YS; Yuan, HT; Zhang, HC | 1 |
| Beer, JC; Cottin, Y; Guenancia, C; Lorgis, L; Lorin, J; Rochette, L; Stamboul, K; Touzery, C; Vergely, C; Zeller, M | 1 |
| Berge, RK; Bohov, P; Borgeraas, H; Hertel, JK; Hjelmesæth, J; Nygård, O; Seifert, R; Ueland, PM | 1 |
| Borgeraas, H; Hertel, JK; Hjelmesæth, J; Nygård, O; Pedersen, ER; Seifert, R; Svingen, GF | 1 |
| Rahmani-Nia, F; Ranjbar, K; Shahabpour, E | 1 |
| Atzler, D; Boeing, H; Böger, RH; Cordts, K; di Giuseppe, R; Menzel, J; Schwedhelm, E; Weikert, C; Wirth, J | 1 |
| Chen, B; Chen, J; Huang, Y; Li, S; Liang, Z; Luo, L; Wu, W; Yin, Y | 1 |
| Au Yeung, SL; Lam, HS; Lin, SL; Schooling, CM | 1 |
| Cottin, Y; Guenancia, C; Guilland, JC; Lorin, J; Rochette, L; Stamboul, K; Vergely, C; Zeller, M | 1 |
| Gonon, AT; Kiss, A; Pernow, J; Sjöquist, PO; Tratsiakovich, Y; Yang, J | 1 |
| Gonon, AT; Kiss, A; Mahdi, A; Pernow, J; Podesser, BK; Tratsiakovich, Y; Yang, J | 1 |
| Cooke, JP; Metzler, B; Stuehlinger, MC | 1 |
| Baron, SJ; Cruz-Gonzalez, I; Healy, JL; Jang, IK; McNulty, IA; Pomerantsev, E; Yeh, RW | 1 |
| Cavusoglu, E; Chopra, V; Eng, C; Marmur, JD; Pinsky, DJ; Ruwende, C; Yanamadala, S | 1 |
| Boontje, NM; de Crom, R; de Waard, MC; Dekkers, DH; Duncker, DJ; Kuster, DW; Lamers, JM; van der Velden, J; van Haperen, R | 1 |
| Kehl, F; Lange, M; Lotz, C; Redel, A; Roewer, N; Smul, TM; Stumpner, J | 1 |
| Gray, GA; Leiper, JM; Malaki, M; Miller, AA; Patrizio, M; Sherry, L; Vallance, P; Wallace, AF | 1 |
| Dangas, G | 1 |
| Gonon, AT; Jung, C; Lundberg, JO; Pernow, J; Sjöquist, PO | 1 |
| Alexander, JH; Dzavik, V; Geppert, A; Hochman, JS; Katz, JN; Pieper, KS; Reynolds, HR; Ruzyllo, W; Stebbins, AL; Van de Werf, F; Werdan, K | 1 |
| Erikson, JM; Lao, S; Wilson, BS; Xu, X; Zhang, JQ; Zhao, W | 1 |
| Luo, XP; Shi, HM; Sun, T; Tang, YL; Zhou, WB | 1 |
| Cavusoglu, E; Chopra, V; Eng, C; Frishman, WH; Marmur, JD; Pinsky, DJ; Poludasu, S; Ruwende, C; Yanamadala, S | 1 |
| Ceballos-Reyes, G; Chamorro-Cevallos, G; Hernández-Navarro, MD; Mora-Escobedo, R; Ortiz-Moreno, A; Piñeiro, V | 1 |
| Ajtay, Z; Awiszus, F; Bode-Böger, SM; Cziráki, A; Martens-Lobenhoffer, J; Németh, A; Sulyok, E; Szabados, S; Szabó, C | 1 |
| Aoyama, T; Fujiwara, H; Fujiwara, T; Iwasa, M; Kawamura, I; Kobayashi, H; Minatoguchi, S; Nishigaki, K; Shiraki, T; Sumi, S; Takemura, G; Ushikoshi, H; Yamada, Y; Yamaki, T; Yasuda, S | 1 |
| Chmiel, A; Gąsior, Z; Gieszczyk, K; Haberka, M; Janowska, J; Mizia, M; Mizia-Stec, K; Zahorska-Markiewicz, B | 1 |
| Głowacki, R; Heród, P; Jakubowski, H; Kazek, G; Machnik, A; Undas, A; Zaąbczyk, M | 1 |
| Chen, M; Huo, Y; Li, J; Lou, L; Pan, C; Singh, G; Wang, S; Wu, A; Zhang, D; Zhao, M | 1 |
| Bekpinar, S; Gurdol, F; Umman, B; Unlucerci, Y; Yilmaz, A | 1 |
| Pendyala, L; Superko, R; Williams, P | 1 |
| Ariëns, RA; Carter, AM; Grant, PJ; Lisman, T; Miedzak, M; Philippou, H; Rosendaal, FR; Uitte de Willige, S | 1 |
| Braun, M; Celec, P; Halčák, L; Hodosy, J; Holzerová, J; Janega, P; Jáni, P; Kalousová, M; Kúdela, M; Murín, J; Parrák, V; Pecháň, I; Šebeková, K; Zima, T | 1 |
| Dioguardi, FS | 1 |
| Chung, MY; Hsu, CP; Lin, CC; Lin, SJ; Lu, TM | 1 |
| Bekpinar, S; Develi, S; Gurdol, F; Unlucerci, Y; Yilmaz, A | 1 |
| Akgul, EO; Cayci, T; Covic, A; Demir, AD; Kanat, S; Kanbay, M; Maden, O; Ozcan, F; Ozlu, MF; Sen, N; Sokmen, E; Turak, O; Yaman, H | 1 |
| Bergheanu, SC; de Jong, MG; Jukema, JW; le Cessie, S; Liem, SS; Schalij, MJ; van der Bom, JG; van der Hoeven, BL; van der Laarse, A | 1 |
| Chai, Y; Dong, X; Li, W; Liao, W; Lou, Z; Tan, G; Zhu, Z | 1 |
| Ceyhan, BM; Dogan, A; Erdogan, D; Ozaydin, M; Sutcu, R; Turker, Y; Yucel, H | 1 |
| Braun-Dullaeus, RC; Ebner, A; Ebner, B; Eckert, T; Lange, SA; Simonis, G; Strasser, RH; Weinbrenner, C; Wischniowski, C; Wunderlich, C | 1 |
| Cavalca, V; De Metrio, M; Marenzi, G; Moltrasio, M; Porro, B; Rubino, M; Squellerio, I; Tremoli, E; Veglia, F | 1 |
| Lewis, BE; Walenga, JM | 1 |
| Higuma, N; Honsako, A; Miida, T; Oda, H; Sakai, K; Takahashi, K | 1 |
| Satler, LF | 1 |
| Devaki, T; Ebenezar, KK; Sathish, V | 1 |
| Lincoff, AM | 1 |
| Ding, YA; Lee, WS; Lin, SJ; Lu, TM; Tai, HC | 1 |
| Amarenco, P; Arveiler, D; Cambien, F; Courbon, D; Ducimetière, P; Elbaz, A; Evans, A; Gariépy, J; Kee, F; Morrison, C; Nicaud, V; Poirier, O | 1 |
| Abidov, A; Behar, S; Cotter, G; Gottlieb, S; Hod, H; Kaluski, E; Leor, J; Vered, Z | 1 |
| Nishio, I; Tsuda, K | 1 |
| Kajiyama, A; Oka, T; Saito, D; Shiraki, T; Takamura, T | 1 |
| Laaksonen, R; Valkonen, VP | 1 |
| Fujii, M; Hirahara, T; Ikeda, N; Kubo, N; Matsushima, K; Ohmura, N; Saito, M; Yasu, T | 1 |
| Bajović, BV; Durić, DM; Jakovljević, VLj; Mujović, VM; Novokmet, SS | 1 |
| Chen, Q; Li, BL; Song, ZJ | 1 |
| Damiano, RJ; Deshpande, SP; Lawton, JS; Zanaboni, PB | 1 |
| Bates, ER; Mukherjee, D | 1 |
| Bhatt, DL; Gurm, HS | 1 |
| Bae, SW; Choi, BY; Choi, YH; Lee, SH; Lee, YS; Pachinger, O; Park, HK; Park, JE; Stühlinger, MC; Yoo, HS; Yu, KH | 1 |
| Bednarz, B; Drozdowska, D; Gessek, J; Gniot, J; Janik, K; Jaxa-Chamiec, T; Kawka-Urbanek, T; Laskowski, H; Maciejewski, P; Szpajer, M | 1 |
| Eriksson, AL; Hedner, T; Ohlsson, C; Wallerstedt, SM | 1 |
| Nasyrov, AG; Rakhmatullina, FF; Zefirov, AL | 1 |
| Avalli, L; Brustia, M; Colagrande, L; Formica, F; Muratore, M; Paolini, G; Porta, F; Sangalli, F | 1 |
| Becker, LC; Capriotti, A; Champion, HC; Ernst, KV; Forman, S; Gerstenblith, G; Hare, JM; Kass, DA; Kelemen, MD; Schulman, SP; Terrin, ML; Townsend, SN | 1 |
| Berti, F; Brini, AT; Clement, MG; De Gennaro Colonna, V; Manfredi, B; Polvani, G; Rossoni, G | 1 |
| Hiroi, T; Ishii, M; Kiuchi, Y; Shimizu, S; Wajima, T | 1 |
| Abumrad, NN; Barbul, A | 1 |
| Bünder, R; Maisch, B; Renz, H; Richter, A; Stief, TW | 1 |
| Boger, RH | 1 |
| Cui, J; Green, R; Han, FY; Randell, E; Renouf, J; Sun, G; Xie, YG | 1 |
| Kreutzkamp, B | 1 |
| Cottin, Y; Duvillard, L; Gambert, P; Guilland, JC; Korandji, C; Moreau, D; Rochette, L; Sicard, P; Vergely, C; Zeller, M | 1 |
| Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Kushnir, MM; May, HT; Muhlestein, JB; Nielson, R; Pasquali, M; Roberts, WL; Rockwood, AL; Schwarz, EL | 1 |
| Bai, X; Jiao, X; Li, M; Liang, F; Liu, H; Liu, L; Wang, X; Zhi, J | 1 |
| Alexander, JH; Dzavik, V; Harrington, RA; Hochman, JS; Reynolds, HR; Stebbins, AL; Van de Werf, F | 1 |
| Eberly, SW; Glazko, G; Goldenberg, I; Mathew, J; McNitt, S; Morray, B; Moss, AJ; Ryan, D; Zareba, W | 1 |
| Bode-Böger, SM; Ignarro, LJ; Scalera, F | 1 |
| Frøbert, O; Hjortshøj, SP; Ravkilde, J; Simonsen, U | 1 |
| Akasaka, T; Kaji, S; Kajiya, F; Mochizuki, S; Ogasawara, Y; Tanemoto, K; Yada, T; Yoshida, K | 1 |
| Teerlink, T | 1 |
| Kielstein, JT; Sydow, K; Thum, T | 1 |
| Jolicoeur, EM; Lopes, RD; Ohman, EM; Wang, T | 1 |
| DelFraino, B; Dzavik, V; Griffith, OW; Hathaway, D; Hazen, SL; Hochman, JS; Koeth, R; Levison, B; Nicholls, SJ; Nissen, SE; Panza, JA; Wang, Z | 1 |
| Arena, R; Guazzi, M; Guazzi, MD | 1 |
| Beer, JC; Cottin, Y; Duvillard, L; Gambert, P; Guilland, JC; Korandji, C; Lagrost, AC; Lorgis, L; Moreau, D; Rochette, L; Sicard, P; Vergely, C; Zeller, M | 1 |
| Bengtsson, C; Björkelund, C; Fogarty, J; Graham, I; Leong, T; Lissner, L; Thelle, D; Ward, D; Zylberstein, D | 1 |
| Fahim, M; Shahid, M; Sharma, KK; Tauseef, M | 1 |
| Hämäläinen, L; Kaste, M; Kauppinen-Mäkelin, R; Kontula, K; Miettinen, H; Palomäki, H; Vuorio, A; Ylikorkala, A | 1 |
| Bing, RJ; Dudek, RR; Giesler, G; Pinto, V; Wildhirt, S | 1 |
| Hammon, JW; McGee, DS; Sato, H; Vinten-Johansen, J; Williams, MW; Zhao, ZQ | 1 |
| Hartman, JC | 1 |
| Ramnauth, S; Taft, CS; Vinten-Johansen, J; Williams, MW; Zhao, ZQ | 1 |
| Neild, GH; Patel, VC; Woolfson, RG; Yellon, DM | 1 |
| Edelman, ER; Friedman, M; Grossman, W; Harada, K; Sellke, FW; Simons, M; Wang, SY | 1 |
| Kaeffer, N; Richard, V; Thuillez, C; Tron, C | 1 |
| Neild, GH; Patel, VC; Singh, KJ; Woolfson, RG; Yellon, DM | 1 |
| Arnal, JF; el Amrani, AI; Michel, JB | 1 |
| Blanc, T; Kaeffer, N; Richard, V; Thuillez, C; Tron, C | 1 |
| Beisiegel, U; Feussner, G; Fisher, RM; Hamsten, A; Humphries, SE; Mailly, F; Miller, G; Peacock, RE; Seed, M; Yudkin, JS | 1 |
| Carretero, OA; Liu, YH; Sabbath, HN; Sharov, VG; Sigmon, DH; Yang, XP | 1 |
| Borchiellini, A; Montaruli, B; Muleo, G; Pannocchia, A; Schinco, P; Tamponi, G; van Mourik, JA; Voorberg, J | 1 |
| Chatterjee, K; Glantz, SA; Parmley, WW; Shuman, JL; Sievers, RE; Sun, Y; Wolfe, CL; Zhu, B | 1 |
| Akiyama, K; Bing, RJ; Cannavino, C; Grant, P; Horstman, D; Suzuki, H; Wolf, WP | 1 |
| Ardissino, D; Colombi, E; Mannucci, PM; Merlini, PA; Peyvandi, F | 1 |
| Donkin, J; Iaffaldano, R; Lewis, BE; McKiernan, TL; Rao, L; Wallenga, JM | 1 |
| Kleiman, NS | 1 |
| Edland, SD; Higaki, J; Ikegami, H; Kamino, K; Martin, GM; Miki, T; Nakura, J; Ogihara, T; Oshima, J; Rakugi, H; Ye, L | 1 |
| Aiach, M; Aillaud, MF; Alhenc-Gelas, M; Berruyer, M; de Moerloose, P; Dreyfus, M; Emmerich, J; Fiessinger, JN; Garcin, JM; Jude, B; Juhan-Vague, I; Le Querrec, A; Priollet, P; Vallantin, X; Wolf, M | 1 |
| Didion, SP; Mayhan, WG | 1 |
| Verstraete, M | 1 |
| Ding, YF; Ho, SY; Li, YL | 1 |
| Baron, AD; Fei, L; Henry, DP; Zipes, DP | 1 |
| Alford, KL; Becker, JC; Brooks, RL; Hursting, MJ; Joffrion, JL; Knappenberger, GD; Kogan, PW; Kogan, TP; McKinney, AA; Schwarz, RP | 1 |
| Griffin, JH; Petäjä, JM | 1 |
| Gay, WA; Harris, KM; Lee, R; Nitta, T; Schmid, RA; Schuessler, RB | 1 |
| Caron, C; Carrier, M; Martineau, R; Pagé, PL; Pellerin, M; Pelletier, LC; Searle, NR; Solymoss, BC | 1 |
| Bertina, RM; Doggen, CJ; Manger Cats, V; Reitsma, PH; Rosendaal, FR; Vandenbroucke, JP | 1 |
| Enderle, MD; Füllhase, J; Häring, HU; Karsch, KR; Koch, M; Kühn, R; Pfohl, M | 1 |
| Anderson, HV; Bazzino, O; Brown, DF; Dinsmore, R; Dutra, OP; Giugliano, RP; Jang, IK; Liprandi, AS; Losordo, D; Massey, TJ; Nicolau, JC; Norbady, R; Schwarz, RP; Viamonte, VM | 1 |
| Aitchison, KA; Coker, SJ | 1 |
| Armstrong, PW; Choy, JB | 1 |
| Arnold, JM; Arnold, O; Feng, Q; Fortin, AJ; Lu, X | 1 |
| Conrad, N; Horstman, D; Kornberg, A; Reichart, B; Schulze, C; Wildhirt, SM | 1 |
| Arnoletti, JP; Whitman, GJ | 1 |
| Pernow, J; Wang, QD | 1 |
| Lundberg, JM; Thorén, P; Zhang, W | 1 |
| Aubó, C; Marrugat, J; Masiá, R; Sala, J; Sentí, M; Tomás, M; Vila, J | 1 |
| Ahmad, S; Ahsan, A; Fareed, J; Hoppensteadt, DA; Iqbal, O; Lewis, BE; Walenga, JM | 1 |
| Gaudette, GR; Horimoto, H; Krukenkamp, IB; Saltman, AE | 1 |
| Agulló, L; Barrabés, JA; Garcia-Dorado, D; Inserte, J; Mirabet, S; Padilla, F; Paniagua, A; Ruiz-Meana, M; Soler-Soler, J | 1 |
| Campos, H; Sen-Banerjee, S; Siles, X | 1 |
| Besse, P; Darius, H; Fels, PW; Fitzgerald, D; Garrigou, D; Müller, E; Puel, J; Simoons, ML; Vahanian, A; Van de Werf, F; Vermeer, F | 1 |
| White, HD; Wong, CK | 1 |
| Thomas, GD; Victor, RG; Zhang, W | 1 |
| Fleischer, K; Gulba, DC; Lankes, W | 1 |
| Fukuda, N; Hohta, SA; Izumi, T; Kimura, A; Kurosawa, T; Sasaoka, T | 1 |
| Anker, SD; Coats, AJ; Dietz, R; Francis, DP; Gläser, C; Greiser, P; Gross, M; Norwig, A; Rauchhaus, M; Schulz, S; Weidhase, L | 1 |
| Fowler, WC; Johnston, WE; Lefer, DJ; McGee, DS; Nakanishi, K; Vinten-Johansen, J; Zhao, Z | 1 |
| Tomoda, H | 1 |
| Christes, A; Drexler, H; Hablawetz, E; Lu, W; Riede, U | 1 |
| Drexler, H; Lu, W | 1 |
| Asafov, GB; Chernousova, GB; Cherpachenko, NM; Chumachenko, MN; Krivov, VI; Merimson, VG; Mozzhechkov, VT; Ovchinnikov, IA; Rozynov, VG; Smirnov, VN | 1 |
| Bol'shakova, LV; Gomazkov, OA; Komissarova, NV; Teplova, NN | 1 |
| Samofalova, MS | 1 |
18 review(s) available for arginine and Cardiovascular Stroke
| Article | Year |
|---|---|
[Vascular dysfunction in Cardiorenal Syndrome type 4].
Topics: Aorta; Arginine; Autonomic Nervous System Diseases; Bone Diseases, Metabolic; Cardio-Renal Syndrome; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Phosphorus; Renal Insufficiency, Chronic; Toxins, Biological; Tunica Intima; Uric Acid; Vascular Stiffness; Vasculitis | 2020 |
A novel metabolic balance model for describing the metabolic disruption of and interactions between cardiovascular-related markers during acute myocardial infarction.
Topics: Acute Disease; Adenosine Triphosphate; Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular System; Kidney; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley | 2013 |
Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Arginine; Cardiovascular Agents; Double-Blind Method; Humans; Middle Aged; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
To give or not to give? Lessons from the arginine paradox.
Topics: Arginase; Arginine; Humans; Metabolic Networks and Pathways; Models, Biological; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nutrigenomics; Vasodilation | 2011 |
Argatroban in HIT type II and acute coronary syndrome.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Disease; Humans; Myocardial Infarction; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
Topics: Angioplasty, Balloon, Coronary; Arginine; Clinical Trials as Topic; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombolytic Therapy | 2003 |
Asymmetric dimethylarginine (ADMA) and acute vascular events.
Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; Stroke | 2004 |
Current role of antithrombotic agents in the treatment of acute coronary syndromes.
Topics: Aged; Anticoagulants; Arginine; Blood Platelets; Clinical Trials as Topic; Enoxaparin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hirudins; Humans; Middle Aged; Models, Biological; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Risk; Sulfonamides; Thrombin | 2004 |
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio.
Topics: Animals; Arginine; Dietary Supplements; Humans; Myocardial Infarction; Nitric Oxide Synthase Type III | 2007 |
Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Chondroitin Sulfates; Comorbidity; Dermatan Sulfate; Drug Therapy, Combination; Fibrinolytic Agents; Fondaparinux; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombocytopenia; Vitamin K | 2007 |
Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
Topics: Anticoagulants; Antithrombins; Arginine; Blood Platelets; Clinical Trials as Topic; Epoprostenol; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Oligopeptides; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Thrombolytic Therapy | 1996 |
Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance.
Topics: Antithrombins; Arginine; Clinical Trials, Phase III as Topic; Fibrinolytic Agents; Hemorrhage; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides | 1997 |
Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor.
Topics: Animals; Antithrombins; Arginine; Clinical Trials, Phase I as Topic; Drug Evaluation, Preclinical; Humans; Molecular Structure; Molecular Weight; Myocardial Infarction; Pipecolic Acids; Sulfonamides; Thrombolytic Therapy | 1997 |
Anticoagulant therapy in unstable angina.
Topics: Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Coronary Thrombosis; Disease Progression; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Warfarin | 1999 |
Medical treatment for acute coronary syndromes.
Topics: Angina, Unstable; Arginine; Coronary Angiography; Fibrinolytic Agents; Heparin; Humans; Metalloendopeptidases; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfonamides; Survival Rate; Syndrome; Thrombolytic Therapy; Tissue Plasminogen Activator | 2000 |
[Direct thrombin antagonists].
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithrombins; Arginine; Azetidines; Benzylamines; Fibrinolytic Agents; Glycine; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Rabbits; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Time Factors | 2001 |
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Topics: Angina, Unstable; Antithrombins; Arginine; Glycine; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Oligopeptides; Peptide Fragments; Pipecolic Acids; Piperidines; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Survival Rate; Thrombin | 2002 |
14 trial(s) available for arginine and Cardiovascular Stroke
| Article | Year |
|---|---|
Tobacco smoke exposure and endothelial dysfunction in patients with advanced coronary artery disease.
Topics: Arginine; Biomarkers; Comorbidity; Coronary Artery Disease; Cotinine; Disease Progression; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Regression Analysis; Smoking; Thrombomodulin; Tobacco Smoke Pollution | 2013 |
[Salvia Miltiorrhiza reduces plasma levels of asymmetric ADMA in patients with non-ST elevation myocardial infarction undergoing percutaneous coronary intervention].
Topics: Arginine; Drugs, Chinese Herbal; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Salvia miltiorrhiza | 2014 |
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.
Topics: Aged; Arginine; Coronary Vessels; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Norepinephrine; Ontario; Prognosis; Prospective Studies; Shock, Cardiogenic; Survival Rate; Time Factors; United States; Vascular Patency; Vasoconstrictor Agents | 2009 |
N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Blood Flow Velocity; Dietary Supplements; Dilatation, Pathologic; Endothelium, Vascular; Fatty Acids, Omega-3; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Treatment Outcome; Ultrasonography | 2011 |
[Prospective randomized study of argatroban versus heparin anticoagulation therapy after percutaneous coronary intervention for acute myocardial infarction].
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Restenosis; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Prospective Studies; Sulfonamides | 2004 |
Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial.
Topics: Administration, Oral; Aged; Arginine; Double-Blind Method; Female; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Pilot Projects; Treatment Outcome | 2005 |
L-arginine effects on myocardial stress in cardiac surgery: preliminary results.
Topics: Arginine; Biomarkers; Coronary Artery Bypass; Creatine Kinase, MB Form; Echocardiography, Transesophageal; Follow-Up Studies; Heart Arrest, Induced; Heart Ventricles; Humans; Interleukin-6; Intraoperative Period; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Pulmonary Wedge Pressure; Receptors, Interleukin-2; Retrospective Studies; Treatment Outcome; Troponin T; Tumor Necrosis Factor-alpha; Vascular Resistance | 2005 |
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.
Topics: Aged; Arginine; Atherosclerosis; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Ventricular Function, Left | 2006 |
Monitoring of plasmin and plasminogen activator activity in blood of patients under fibrinolytic treatment by reteplase.
Topics: Arginine; Blood Specimen Collection; Fibrinolysin; Fibrinolytic Agents; Humans; Kinetics; Myocardial Infarction; Plasminogen Activators; Recombinant Proteins; Tissue Plasminogen Activator | 2006 |
Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
Topics: Aged; Arginine; Blood Pressure; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Prospective Studies; Protein Isoforms; Shock, Cardiogenic; Vascular Patency; Vasoconstrictor Agents | 2007 |
Can L-arginine improve myocardial protection during cardioplegic arrest? Results of a phase I pilot study.
Topics: Arginine; Blood; Cardioplegic Solutions; Cause of Death; Cold Temperature; Coronary Artery Bypass; Creatine Kinase; Feasibility Studies; Female; Follow-Up Studies; Heart; Heart Arrest, Induced; Hot Temperature; Humans; Isoenzymes; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pilot Projects; Safety; Survival Rate; Thoracic Arteries; Troponin I | 1998 |
A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
Topics: Adult; Arginine; Chemotherapy, Adjuvant; Coronary Angiography; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Recurrence; Single-Blind Method; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 1999 |
Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using high performance liquid chromatography and functional methods.
Topics: Anticoagulants; Antithrombins; Arginine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Hemorrhage; Humans; Male; Myocardial Infarction; Pipecolic Acids; Sensitivity and Specificity; Streptokinase; Sulfonamides; Time Factors | 1999 |
Argatroban and alteplase in patients with acute myocardial infarction: the ARGAMI Study.
Topics: Aged; Angiography; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pipecolic Acids; Plasminogen Activators; Sulfonamides; Survival Rate; Time Factors; Tissue Plasminogen Activator | 2000 |
135 other study(ies) available for arginine and Cardiovascular Stroke
| Article | Year |
|---|---|
Expression of cardiovascular-related microRNAs is altered in L-arginine:glycine amidinotransferase deficient mice.
Topics: Amidinotransferases; Animals; Arginine; Creatine; Heart Failure; Homoarginine; Mice; MicroRNAs; Myocardial Infarction | 2022 |
L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic.
Topics: Arginine; Cardiac Rehabilitation; COVID-19; Heart; Humans; Myocardial Infarction; Nitric Oxide Synthase; Pandemics | 2022 |
Improved Cardiac Function Following Ischemia Reperfusion Injury Using Exercise Preconditioning and L-Arginine Supplementation via Oxidative Stress Mitigation and Angiogenesis Amelioration.
Topics: Animals; Arginine; Dietary Supplements; High-Intensity Interval Training; Humans; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neovascularization, Physiologic; Oxidative Stress; Rats; Rats, Wistar | 2022 |
Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure.
Topics: Animals; Arginine; Creatine; Female; Heart Failure; Homoarginine; Humans; Mice; Myocardial Infarction; Myocardium | 2023 |
Analysis of L-arginine:glycine amidinotransferase-, creatine- and homoarginine-dependent gene regulation in the murine heart.
Topics: Amidinotransferases; Animals; Arginine; Connective Tissue Growth Factor; Creatine; Desmocollins; Disease Models, Animal; Energy Metabolism; Fibrinogen; Gene Expression Regulation; Genetic Association Studies; Homoarginine; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Mice, Transgenic; Myocardial Infarction; Myocardium; Potassium Channels; Transcriptome | 2020 |
To be, or not to be BAME, in the time of COVID-19: does it matter?
Topics: Arginine; COVID-19; Humans; Myocardial Infarction; Pandemics; Race Factors; SARS-CoV-2 | 2021 |
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry | 2017 |
Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function.
Topics: Animals; Apoptosis; Arginine; Collagen; Diastole; Erythropoietin; Glutathione; Heart; Hematocrit; Hemoglobins; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Rats | 2018 |
Association of serum asymmetric dimethyl-arginine and troponin I levels as a risk of myocardial infarction in thalassemia.
Topics: Arginine; Biomarkers; Case-Control Studies; Creatine Kinase, MB Form; Humans; L-Lactate Dehydrogenase; Myocardial Infarction; Risk Factors; Thalassemia; Troponin I | 2018 |
Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction.
Topics: Amidohydrolases; Animals; Arginine; Caffeic Acids; Chromatography, High Pressure Liquid; Creatinine; Disease Models, Animal; Heart Ventricles; Kidney; Lactates; Liver; Male; Myocardial Infarction; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2013 |
Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.
Topics: Animals; Arginase; Arginine; Coronary Vessels; Myocardial Infarction; Nitric Oxide; Rats; Reperfusion Injury | 2013 |
[Acute myocardial infarction with simultaneous occlusions of two coronary arteries in a 44 year-old man].
Topics: Adult; Arginine; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Dietary Supplements; Electrocardiography; Humans; Male; Myocardial Infarction | 2013 |
High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.
Topics: Animals; Arginine; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Hypercholesterolemia; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Rats; Rats, Wistar | 2013 |
High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction.
Topics: Aged; Arginine; Chromatography, High Pressure Liquid; Female; Humans; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction | 2013 |
Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats.
Topics: Animals; Arginine; Cardiotonic Agents; Erythropoietin; Gene Transfer Techniques; Male; Myocardial Infarction; Myocardium; Polyamines; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2013 |
Asymmetric dimethylarginine and oxidative stress following coronary artery bypass grafting: associations with postoperative outcome.
Topics: Aged; Arginine; Coronary Artery Bypass; Dinoprost; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Postoperative Complications | 2014 |
Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair.
Topics: Animals; Arginine; Disease Models, Animal; Drug Delivery Systems; Gene Silencing; Heart; Hypoxia-Inducible Factor-Proline Dioxygenases; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Nanoparticles; Polyamines; RNA, Small Interfering | 2014 |
Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, High Pressure Liquid; Electrocardiography; Endothelium; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Oxidative Stress; Risk Assessment; Risk Factors | 2015 |
Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study.
Topics: Aged; Arginine; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Trans Fatty Acids | 2016 |
Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris.
Topics: Angina, Stable; Arginine; Body Mass Index; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitrogen Oxides; Norway; Risk Factors | 2016 |
Aerobic training and l-arginine supplementation promotes rat heart and hindleg muscles arteriogenesis after myocardial infarction.
Topics: Angiogenesis Inducing Agents; Angiostatins; Animals; Arginine; Arterioles; Arteriolosclerosis; Combined Modality Therapy; Coronary Vessels; Dietary Supplements; Gene Expression Regulation; Heart; Hindlimb; Male; Motor Activity; Muscle, Skeletal; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Physical Conditioning, Animal; Random Allocation; Rats, Wistar; Transforming Growth Factor beta | 2016 |
Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
Topics: Adult; Aged; Arginine; Biomarkers; Feeding Behavior; Female; Germany; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Prospective Studies; Risk | 2017 |
Cardioprotective activity of placental growth factor combined with oral supplementation of l-arginine in a rat model of acute myocardial infarction.
Topics: Animals; Arginine; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Heart Ventricles; Myocardial Infarction; Placenta Growth Factor; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2016 |
Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: A Mendelian randomization study.
Topics: Arginine; Female; Genome-Wide Association Study; Humans; Male; Mediator Complex; Mendelian Randomization Analysis; Myocardial Infarction; Polymorphism, Single Nucleotide; Transaminases | 2016 |
Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.
Topics: Aged; Arginine; Female; Glomerular Filtration Rate; Heart Failure; Hospitals; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Prognosis; Renal Insufficiency, Chronic; Treatment Outcome; Ventricular Function, Left | 2017 |
Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arginase; Arginine; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Kinase Inhibitors; Rats, Sprague-Dawley; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction | 2017 |
Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Arginase; Arginine; Down-Regulation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nicotinic Antagonists; Random Allocation; Rats; Rats, Sprague-Dawley; Vagus Nerve Stimulation | 2017 |
Letter by Stuehlinger et al regarding article, "Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction".
Topics: Aged; Arginine; Biomarkers; Citrulline; Hemodynamics; Humans; Male; Methylation; Myocardial Infarction; Nitric Oxide; Ornithine; Oxidation-Reduction; Oxidative Stress; Predictive Value of Tests; Shock, Cardiogenic | 2008 |
Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiac Catheterization; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Pipecolic Acids; Retrospective Studies; Risk Assessment; Sulfonamides; Thrombin; Treatment Outcome | 2009 |
Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Arginine; Biomarkers; Coronary Angiography; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; Up-Regulation | 2009 |
Detrimental effect of combined exercise training and eNOS overexpression on cardiac function after myocardial infarction.
Topics: Acetylcysteine; Actin Cytoskeleton; Animals; Antioxidants; Arginine; Biopterins; Disease Models, Animal; Exercise Therapy; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Physical Exertion; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Superoxides; Time Factors; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Pressure; Ventricular Remodeling | 2009 |
Time course of desflurane-induced preconditioning in rabbits.
Topics: Anesthetics, Inhalation; Animals; Arginine; Desflurane; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Myocardial Infarction; Nitric Oxide Synthase; Rabbits; Random Allocation; Time Factors | 2010 |
Immunolocalisation and activity of DDAH I and II in the heart and modification post-myocardial infarction.
Topics: Amidohydrolases; Animals; Aorta; Arginine; Disease Models, Animal; Endocardium; Heart Ventricles; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein-Arginine N-Methyltransferases; Rats; Rats, Wistar | 2010 |
Clinical investigation in ACS and PCI: shooting in the dark at a moving target.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Evidence-Based Medicine; Hemorrhage; Humans; Myocardial Infarction; Myocardial Revascularization; Pipecolic Acids; Research Design; Risk Assessment; Sulfonamides; Thrombin; Treatment Outcome | 2009 |
Play it safe, avoid L-arginine supplements.
Topics: Arginine; Cardiovascular Diseases; Dietary Supplements; Humans; Myocardial Infarction; Nitric Oxide | 2006 |
Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.
Topics: Amino Acids; Animals; Arginase; Arginine; Blood Pressure; Enzyme Inhibitors; Heart Rate; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley | 2010 |
Effects of exercise and L-arginine on ventricular remodeling and oxidative stress.
Topics: Animals; Arginine; Echocardiography; Enzyme Inhibitors; Free Radicals; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Oxidative Stress; Physical Conditioning, Animal; Polymerase Chain Reaction; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sequence Analysis, DNA; Survival Analysis; Ventricular Remodeling | 2010 |
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Diabetes Complications; Humans; Male; Myocardial Infarction; Prognosis; Proportional Hazards Models; Stroke | 2010 |
Effect of L-arginine oral supplementation on response to myocardial infarction in hypercholesterolemic and hypertensive rats.
Topics: Administration, Oral; Animals; Arginine; Blood Pressure; Cardiovascular Agents; Dietary Supplements; Hypercholesterolemia; Hypertension; Male; Myocardial Infarction; Myocardium; Nitric Oxide; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2010 |
Effects of stent implementation on plasma levels of asymmetric dimethylarginine in patients with or without ST-segment elevation acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Arginine; Case-Control Studies; Coronary Angiography; Female; Humans; Male; Methylation; Middle Aged; Myocardial Infarction; Ornithine; Stents; Ultrasonography | 2010 |
Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits.
Topics: alpha-Glucosidases; Animals; Arginine; Decanoic Acids; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Heart; Hydroxy Acids; Hypoglycemic Agents; Inositol; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphotransferases; Proto-Oncogene Proteins c-akt; Rabbits; Receptors, Glucagon; Reperfusion Injury | 2010 |
Elevated concentrations of Nɛ-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation.
Topics: Arginine; Autoantibodies; Dipeptides; Endothelium; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Thrombin | 2011 |
Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Topics: Abietanes; Amino Acid Transport Systems, Basic; AMP-Activated Protein Kinases; Analysis of Variance; Animals; Arginine; Benzofurans; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Cells, Cultured; Chromones; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Endothelial Cells; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; Time Factors; Vasodilation | 2011 |
High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction.
Topics: Angioplasty; Arginine; Biomarkers; Blood Circulation; Electrocardiography; Female; Humans; Lipid Metabolism; Male; Microvessels; Middle Aged; Myocardial Infarction; Reperfusion; Risk Factors | 2011 |
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.
Topics: Arginine; Canada; Case-Control Studies; Comparative Genomic Hybridization; Computer Simulation; Coronary Disease; Cross-Sectional Studies; Drug Interactions; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinesins; Logistic Models; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Prospective Studies; Research Design; Risk Assessment; Risk Factors; Selection Bias; Survival Analysis; Treatment Outcome; Tryptophan | 2011 |
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction.
Topics: Adult; alpha-2-Antiplasmin; Amino Acid Sequence; Amino Acid Substitution; Arginine; Case-Control Studies; Genotype; Humans; Lysine; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Myocardial Infarction; Polymorphism, Single Nucleotide; Protein Processing, Post-Translational; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Validation Studies as Topic | 2011 |
Advanced glycation end products in myocardial reperfusion injury.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Arginine; Cardiac Surgical Procedures; Disease Models, Animal; Fasting; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Neopterin; Rabbits; Stroke Volume; Thrombolytic Therapy; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Young Adult | 2012 |
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Albuminuria; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, High Pressure Liquid; Disease-Free Survival; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Taiwan; Time Factors | 2011 |
Serum levels of arginase I are associated with left ventricular function after myocardial infarction.
Topics: Arginase; Arginine; Case-Control Studies; Humans; Myocardial Infarction; Stroke Volume; Ventricular Function, Left | 2011 |
Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
Topics: Aged; Arginine; Coronary Angiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Prognosis | 2011 |
Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarction.
Topics: Aged; Arginine; Biomarkers; Blood Pressure; Body Mass Index; Circadian Rhythm; Cross-Sectional Studies; Female; Humans; Linear Models; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Nitrogen Oxides; Platelet Activation; Time Factors | 2011 |
Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications.
Topics: Amino Acids, Branched-Chain; Animals; Arginine; Biological Transport; Biomarkers; Chromatography, Reverse-Phase; Coronary Vessels; Drugs, Chinese Herbal; Fatty Acids; Hydrophobic and Hydrophilic Interactions; Metabolome; Metabolomics; Myocardial Infarction; Phenylalanine; Phospholipids; Proline; Rats; Sphingolipids; Tryptophan | 2012 |
Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
Topics: Arginine; Case-Control Studies; Coronary Angiography; Coronary Circulation; Demography; Female; Hemorheology; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nitric Oxide | 2012 |
Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarction.
Topics: Animals; Arginine; Blood Pressure; Cardiotonic Agents; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Neuregulin-1; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Signal Transduction | 2013 |
Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
Topics: Aged; Arginine; Endpoint Determination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Proportional Hazards Models; Renal Insufficiency, Chronic; Treatment Outcome; Ultrasonography | 2012 |
Obstinate thrombosis during percutaneous coronary intervention in a case with heparin-induced thrombocytopenia with thrombosis syndrome successfully treated by argatroban anticoagulant therapy.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiac Catheterization; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Pipecolic Acids; Radiography; Risk Assessment; Sulfonamides; Syndrome; Thrombocytopenia; Treatment Outcome | 2003 |
Direct thrombin inhibitors during PCI.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Radiography; Risk Assessment; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2003 |
Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats.
Topics: Animals; Arginine; Cell Membrane; Disease Models, Animal; Hydrolases; Isoproterenol; Lysine; Lysosomes; Male; Myocardial Infarction; Myocardium; Phosphoric Monoester Hydrolases; Rats; Rats, Wistar; Reference Values | 2003 |
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Disease; Death, Sudden, Cardiac; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Myocardial Infarction; Nitric Oxide Synthase; Prospective Studies; Risk Factors; Survival Analysis | 2003 |
Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness--the ECTIM, AXA, EVA and GENIC Studies.
Topics: Adult; Aged; Antigens, CD; Arginine; Arteriosclerosis; Brain Infarction; Carotid Arteries; Cross-Sectional Studies; Exons; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Glutamine; Humans; Introns; Male; Middle Aged; Mutation; Myocardial Infarction; Odds Ratio; Polymorphism, Genetic; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tunica Intima; Tunica Media; Ultrasonography | 2004 |
Influence of conduction disturbances on clinical outcome in patients with acute myocardial infarction receiving thrombolysis (results from the ARGAMI-2 study).
Topics: Arginine; Electrocardiography; Female; Heart Block; Heparin; Hospitalization; Humans; Intensive Care Units; Israel; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pipecolic Acids; Prospective Studies; Randomized Controlled Trials as Topic; Severity of Illness Index; Streptokinase; Sulfonamides; Survival Analysis; Thrombolytic Therapy | 2004 |
Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Myocardial Infarction; Nitric Oxide; Risk; Risk Factors | 2004 |
Effect of short-term administration of high dose L-arginine on restenosis after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Coronary Restenosis; Cyclic GMP; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide | 2004 |
[Effects of platelet single passage on coronary circulation in the isolated guinea-pig heart: focus on the L-arginine: nitric oxide system].
Topics: Animals; Arginine; Blood Flow Velocity; Blood Platelets; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase | 2003 |
[Protective effect of tetramethylpyrazine and L-arginine on rats with acute myocardial infarction].
Topics: Animals; Arginine; Creatine Kinase; Drug Synergism; Female; Male; Myocardial Infarction; P-Selectin; Pyrazines; Rats; Rats, Sprague-Dawley; Troponin T | 2004 |
Spontaneous atrioventricular groove disruption during off-pump coronary artery bypass grafting.
Topics: Aged; Anticoagulants; Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass, Off-Pump; Coronary Stenosis; Emergencies; Fatal Outcome; Female; Heart Injuries; Heparin; Humans; Hypertension, Pulmonary; Internal Mammary-Coronary Artery Anastomosis; Intraoperative Complications; Mitral Valve; Myocardial Infarction; Pipecolic Acids; Postoperative Complications; Rupture, Spontaneous; Sulfonamides; Suture Techniques; Thrombocytopenia; Thromboembolism | 2005 |
Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Topics: Adult; Aged; alpha-Tocopherol; Angina, Unstable; Angioplasty, Balloon, Coronary; Arginine; C-Reactive Protein; Cardiovascular Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Insulin; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Statistics as Topic; Treatment Outcome; Triglycerides | 2005 |
Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic beta2 receptor in a Swedish hypertensive population.
Topics: Arginine; Blood Pressure; Cohort Studies; Female; Glutamic Acid; Glutamine; Glycine; Haplotypes; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Prospective Studies; Receptors, Adrenergic, beta-2; Sweden | 2005 |
The course of experimental myocardial infarction under conditions of Suppressed and enhanced NO synthesis.
Topics: Animals; Arginine; Enzyme Inhibitors; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats | 2005 |
Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats.
Topics: Animals; Arginine; Arrhythmias, Cardiac; Cardiotonic Agents; Creatine Kinase; Epoprostenol; Isosorbide Dinitrate; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Naproxen; Nitric Oxide; Peroxidase; Polydeoxyribonucleotides; Random Allocation; Rats; Rats, Wistar; Thromboxane B2 | 2006 |
Reduction of myocardial infarct size by tetrahydrobiopterin: possible involvement of mitochondrial KATP channels activation through nitric oxide production.
Topics: Animals; Anti-Arrhythmia Agents; Arginine; Biopterins; Cyclic GMP; Decanoic Acids; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxy Acids; Male; Malondialdehyde; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitrites; Potassium Channels; Rats; Rats, Sprague-Dawley | 2006 |
Arginine therapy for acute myocardial infarction.
Topics: Arginine; Humans; Myocardial Infarction | 2006 |
Letter to the editor re: JAMA article on L-arginine therapy in acute myocardial infarction.
Topics: Arginine; Dietary Supplements; Humans; Myocardial Infarction; Nitric Oxide Synthase | 2006 |
Thrombospondin-4 1186G>C (A387P) is a sex-dependent risk factor for myocardial infarction: a large replication study with increased sample size from the same population.
Topics: Age Factors; Alleles; Arginine; Cohort Studies; Female; Genetic Variation; Homozygote; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Proline; Risk Factors; Sample Size; Sex Characteristics; Thrombospondins | 2006 |
[Decreased mortality with the use of L-arginine?].
Topics: Acute Disease; Arginine; Humans; Myocardial Infarction; Myocardium; Randomized Controlled Trials as Topic | 2006 |
Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
Topics: Aged; Arginine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Regression Analysis; Risk Factors; Statistics, Nonparametric; Stereoisomerism | 2007 |
Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
Topics: Arginine; Biomarkers; Blood Glucose; C-Peptide; Case-Control Studies; Coronary Disease; Cortisone; Diabetes Mellitus; Female; Humans; Hydrocortisone; Hyperinsulinism; Logistic Models; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Predictive Value of Tests; Risk Assessment | 2007 |
Diverse effects of L-arginine on cardiac function of rats subjected to myocardial ischemia and reperfusion in vivo.
Topics: Animals; Apoptosis; Arginine; Blood Pressure; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Peroxynitrous Acid; Rats; Rats, Wistar; Time Factors; Ventricular Function, Left | 2007 |
Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Arginine; Aryldialkylphosphatase; Aspartic Acid; Cohort Studies; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors | 2007 |
Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.
Topics: Angioplasty, Balloon, Coronary; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Artery Disease; Endothelium; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Prospective Studies | 2008 |
Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments.
Topics: Adult; Aged; Arginine; Biopterins; Case-Control Studies; Drug Therapy; Endothelium, Vascular; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Oxidative Stress; Superoxides | 2007 |
Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
Topics: Arginine; Enzyme Inhibitors; Humans; Myocardial Infarction; Nitric Oxide Synthase; Shock, Cardiogenic; Vasoconstrictor Agents | 2007 |
Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
Topics: Arginine; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Myocardial Infarction; Nitric Oxide Synthase; Shock, Cardiogenic; Vasoconstrictor Agents | 2007 |
Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction.
Topics: Aged; Arginine; Biomarkers; Citrulline; Humans; Male; Methylation; Myocardial Infarction; Nitric Oxide; Ornithine; Oxidation-Reduction; Oxidative Stress; Predictive Value of Tests; Shock, Cardiogenic | 2007 |
Evolving changes in lung interstitial fluid content after acute myocardial infarction: mechanisms and pathophysiological correlates.
Topics: Acute Disease; Adult; Aged; Angioplasty, Balloon, Coronary; Arginine; Blood Pressure; Blood-Air Barrier; C-Reactive Protein; Capillaries; Diffusion; Echocardiography, Doppler; Electrocardiography; Extracellular Fluid; Female; Hematocrit; Humans; Hypertrophy, Left Ventricular; Lung; Male; Membranes; Middle Aged; Myocardial Infarction; Pulmonary Alveoli; Respiratory Function Tests; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2008 |
Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis | 2008 |
Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
Topics: Adult; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Longitudinal Studies; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Sweden | 2008 |
Brief femoral artery ischaemia provides protection against myocardial ischaemia-reperfusion injury in rats: the possible mechanisms.
Topics: Animals; Arginine; Blood Pressure; Creatine Kinase, MB Form; Diazoxide; Disease Models, Animal; Femoral Artery; Heart Rate; Hindlimb; Ischemia; Ischemic Preconditioning, Myocardial; KATP Channels; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Wistar; Reactive Oxygen Species; Vasodilator Agents | 2008 |
Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction.
Topics: Adult; Arginine; Brain Ischemia; Factor V; Female; Finland; Glycine; Humans; Male; Middle Aged; Myocardial Infarction; Point Mutation; Survivors | 1995 |
Dexamethasone inhibits the expression of an inducible nitric oxide synthase in infarcted rabbit myocardium.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Citrulline; Coronary Vessels; Cyclic GMP; Dexamethasone; Ligation; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Rabbits | 1994 |
Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury.
Topics: Acetylcholine; Amino Acid Oxidoreductases; Animals; Arginine; Blood; Calcimycin; Coronary Vessels; Creatine Kinase; Dogs; Heart; Heart Arrest, Induced; Hemodynamics; Hypothermia, Induced; In Vitro Techniques; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Peroxidase; Sodium Nitrite; Vasodilation | 1995 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Heart; Isomerism; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rabbits | 1995 |
Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism.
Topics: Adenosine; Animals; Arginine; Lactates; Lactic Acid; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Rabbits; Theophylline; Time Factors | 1995 |
Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Alginates; Animals; Arginine; Calcimycin; Coronary Circulation; Coronary Vessels; Drug Carriers; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Glucuronic Acid; Heart; Hexuronic Acids; Indomethacin; Ketanserin; Male; Microcirculation; Muscle Relaxation; Myocardial Infarction; Myocardium; Nitroarginine; Nitroprusside; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Sepharose; Serotonin; Swine; Thromboxane A2; Vasodilation | 1994 |
Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion.
Topics: Acetylcholine; Animals; Arginine; Calcimycin; Coronary Vessels; Endothelium, Vascular; Male; Molsidomine; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Serotonin; Vasodilator Agents | 1994 |
Inhibition of nitric oxide limits infarct size in the in situ rabbit heart.
Topics: Analysis of Variance; Animals; Arginine; Blood Pressure; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits | 1993 |
Atrial natriuretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differently.
Topics: Animals; Aorta; Aorta, Abdominal; Aorta, Thoracic; Arginine; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cyclic GMP; Disease Models, Animal; Infusions, Intravenous; Lung; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Renin | 1993 |
Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide.
Topics: Acetylcholine; Animals; Arginine; Blood Pressure; Coronary Vessels; Disease Models, Animal; Endothelium, Vascular; Heart Rate; In Vitro Techniques; Male; Molsidomine; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Potassium Channel Blockers; Rats; Rats, Wistar; Vasodilator Agents | 1995 |
Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Arginine; Base Sequence; Body Mass Index; Case-Control Studies; Female; Genetic Variation; Humans; Hyperlipidemias; Lipoprotein Lipase; Male; Middle Aged; Molecular Sequence Data; Mutation; Myocardial Infarction; Serine; Survivors; Triglycerides | 1995 |
Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Arrhythmias, Cardiac; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Hemodynamics; Indomethacin; Male; Myocardial Infarction; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ramipril; Rats; Rats, Inbred Lew; Reperfusion Injury | 1996 |
Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.
Topics: Adult; Arginine; Base Sequence; Factor V; Female; Glutamine; Heterozygote; Homozygote; Humans; Italy; Male; Molecular Sequence Data; Mutation; Myocardial Infarction; Pedigree; Thrombophlebitis; Thrombosis | 1996 |
L-arginine decreases infarct size in rats exposed to environmental tobacco smoke.
Topics: Animals; Aorta, Abdominal; Arginine; Blood Pressure; Carbon Monoxide; Disease Models, Animal; Endothelium, Vascular; Environmental Exposure; Heart Rate; Isomerism; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Nicotine; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Tobacco Smoke Pollution | 1996 |
Effect of inhibitors of inducible form of nitric oxide synthase in infarcted heart muscle.
Topics: Animals; Arginine; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Heart; Isothiuronium; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rabbits | 1996 |
Factor V (Arg 506-->Gln) mutation in young survivors of myocardial infarction.
Topics: Adult; Age Factors; Arginine; Case-Control Studies; Factor V; Female; Heterozygote; Homozygote; Humans; Male; Myocardial Infarction; Point Mutation | 1996 |
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Female; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1996 |
Association of a polymorphic variant of the Werner helicase gene with myocardial infarction in a Japanese population.
Topics: Adult; Age of Onset; Aged; Arginine; Case-Control Studies; Cysteine; Diabetes Mellitus, Type 2; Female; Genetic Variation; Homozygote; Humans; Japan; Male; Middle Aged; Mutation; Myocardial Infarction; Polymorphism, Genetic; Werner Syndrome | 1997 |
Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation.
Topics: Adult; Aged; Arginine; Case-Control Studies; Extremities; Factor V; Female; Glutamine; Homozygote; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Point Mutation; Risk Factors; Sex Characteristics; Thrombosis | 1997 |
Effect of chronic myocardial infarction on in vivo reactivity of skeletal muscle arterioles.
Topics: Acetylcholine; Animals; Arginine; Arterioles; Calcitonin Gene-Related Peptide; Chronic Disease; Hemodynamics; Male; Muscle, Skeletal; Myocardial Infarction; Nitroprusside; Rats; Rats, Sprague-Dawley; Substance P; Vasomotor System | 1997 |
[Ischemic preconditioning and exogenous L-arginine reduce infarct size in rabbit heart].
Topics: Animals; Arginine; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitroarginine; Rabbits | 1996 |
Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properti
Topics: Animals; Arginine; Confounding Factors, Epidemiologic; Disease Models, Animal; Dogs; Electric Stimulation; Enzyme Inhibitors; Myocardial Contraction; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pericardium; Severity of Illness Index; Tachycardia, Ventricular | 1997 |
Activated protein C resistance: What have we learned now that the dust has settled?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation Disorders; Cerebrovascular Disorders; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophlebitis; Thrombosis | 1997 |
Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size.
Topics: Anesthetics, Local; Animals; Arginine; Cardiovascular Agents; Coloring Agents; Coronary Vessels; Echocardiography; Heart Ventricles; Image Processing, Computer-Assisted; Infusions, Intravenous; Lidocaine; Lissamine Green Dyes; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Random Allocation; Sodium Chloride; Swine; Tetrazolium Salts; Ventricular Function, Left | 1998 |
A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men.
Topics: Adult; Aged; Antigens; Arginine; Case-Control Studies; Factor VII; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors | 1998 |
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Topics: Arginine; Aryldialkylphosphatase; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; DNA; Esterases; Female; Gene Frequency; Genotype; Glutamine; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic | 1999 |
Cyclooxygenase inhibition converts the effect of nitric oxide synthase inhibition from infarct size reduction to expansion in isolated rabbit hearts.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Hemodynamics; In Vitro Techniques; Indomethacin; Male; Myocardial Infarction; Myocardial Reperfusion; Nitric Oxide Synthase; Nitroarginine; Rabbits | 1999 |
Effects of L-arginine on endothelial and cardiac function in rats with heart failure.
Topics: Animals; Aorta, Thoracic; Arginine; Endothelium, Vascular; Heart; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Nitrates; Nitrites; Rats; Rats, Sprague-Dawley; Vasodilation | 1999 |
Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion--implications for iNOS-mediated myocardial stunning.
Topics: Animals; Arginine; Coronary Circulation; Enzyme Activation; Enzyme Inhibitors; Guanidines; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardial Stunning; Myocardium; Nitric Oxide Synthase; Rabbits; Ventricular Function, Left | 1999 |
Heparin-induced thrombocytopenia in coronary bypass surgery.
Topics: Anticoagulants; Arginine; Coronary Artery Bypass; Heparin; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Sulfonamides; Thrombocytopenia | 1999 |
The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
Topics: Animals; Arginine; Coronary Circulation; Creatine Kinase; Enzyme Inhibitors; Heart; Hemodynamics; In Vitro Techniques; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Penicillamine; Perfusion; Rats; Rats, Sprague-Dawley; Swine | 1999 |
The effect of a neuropeptide Y antagonist, BIBP 3226, on short-term arterial pressure control in conscious unrestrained rats with congestive heart failure.
Topics: Animals; Arginine; Blood Pressure; Chronic Disease; Heart Failure; Heart Rate; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stroke Volume; Ventricular Function, Left | 1999 |
Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
Topics: Aged; Arginine; Aryldialkylphosphatase; Case-Control Studies; Cholesterol; Diabetes Mellitus; Diabetic Angiopathies; Esterases; Female; Genotype; Glutamine; Humans; Hyperlipidemias; Logistic Models; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic | 2000 |
The role of nitric oxide, K(+)(ATP) channels, and cGMP in the preconditioning response of the rabbit.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arginine; Coronary Circulation; Cyclic GMP; Enzyme Inhibitors; In Vitro Techniques; Ischemic Preconditioning; Male; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Infarction; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Rabbits | 2000 |
L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig.
Topics: Analysis of Variance; Animals; Arginine; Blood Pressure; Cell Size; Cyclic GMP; Female; Heart Rate; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Random Allocation; Swine | 2000 |
Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction.
Topics: Aged; Alleles; Arginine; Aryldialkylphosphatase; Case-Control Studies; Esterases; Female; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Risk Factors; Smoking | 2000 |
Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress.
Topics: Animals; Arginine; Chronic Disease; Coronary Vessels; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Female; Free Radical Scavengers; Hemodynamics; Hindlimb; Ligation; Malondialdehyde; Muscle, Skeletal; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Oxygen; Phenotype; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sympathetic Nervous System; Vasoconstriction; Ventricular Dysfunction, Left | 2001 |
Polymorphisms in the platelet-endothelial cell adhesion molecule-1 (PECAM-1) gene, Asn563Ser and Gly670Arg, associated with myocardial infarction in the Japanese.
Topics: Amino Acid Substitution; Antigens, CD; Arginine; Asian People; Asparagine; Coronary Stenosis; Female; Gene Frequency; Genotype; Glycine; Humans; Japan; Linkage Disequilibrium; Male; Middle Aged; Mutation, Missense; Myocardial Infarction; Platelet Endothelial Cell Adhesion Molecule-1; Polymorphism, Genetic; Reference Values; Serine | 2001 |
The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Membrane Glycoproteins; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Predictive Value of Tests; Receptors, Fibroblast Growth Factor; Serine; Sialoglycoproteins; Treatment Outcome | 2002 |
Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size.
Topics: Animals; Arginine; Coronary Circulation; Coronary Vessels; Diastole; Dogs; Endothelium, Vascular; Female; Heart; Hemodynamics; In Vitro Techniques; Injections; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Peroxidase; Systole | 1992 |
Experimental evaluation of coronary thrombodynamics and effects of pharmacological interventions in acute coronary syndromes.
Topics: Animals; Antithrombins; Arginine; Coronary Circulation; Coronary Thrombosis; Dogs; Heparin; Myocardial Infarction; Pipecolic Acids; Sulfonamides; Thiophenes; Thrombolytic Therapy; Thromboxane-A Synthase; Urokinase-Type Plasminogen Activator | 1992 |
Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction.
Topics: Animals; Arginine; Blood Pressure; Coronary Circulation; Dipyridamole; Hemodynamics; Male; Myocardial Infarction; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Time Factors; Vascular Resistance | 1992 |
Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure.
Topics: Acetylcholine; Animals; Arginine; Blood Vessels; Cardiac Output, Low; Chronic Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Hindlimb; Male; Myocardial Infarction; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Vascular Resistance | 1992 |
Ammonia neutralization and urea synthesis in cardiac muscle.
Topics: Adult; Ammonia; Animals; Arginase; Arginine; Cardiac Catheterization; Coronary Disease; Coronary Vessels; Humans; Ligation; Male; Middle Aged; Myocardial Infarction; Myocardium; Ninhydrin; Nitrogen; Nitrogen Isotopes; Quaternary Ammonium Compounds; Rats; Urea | 1974 |
[Methodologic approaches to the study of the kallikrein-kinin system in myocardial infarct].
Topics: Aged; Aprotinin; Arginine; Esterases; Female; Humans; Kallikreins; Kinins; Male; Middle Aged; Myocardial Infarction | 1972 |
[Levels of free amino acids in the blood and heart muscle in the human at various periods of myocardial infarct (clinical anatomical parallels)].
Topics: Alanine; Amino Acids; Arginine; Aspartic Acid; Chromatography; Erythrocytes; Glutamates; Glycine; Histidine; Histocytochemistry; Humans; Isoleucine; Leucine; Lysine; Methods; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Phenylalanine; Serine; Threonine; Time Factors; Tyrosine; Valine | 1968 |